• ثبت نام
    • ورود به سامانه
    مشاهده مورد 
    •   صفحهٔ اصلی
    • نشریات انگلیسی
    • Iranian Journal of Pharmaceutical Research
    • Volume 12, Supplement
    • مشاهده مورد
    •   صفحهٔ اصلی
    • نشریات انگلیسی
    • Iranian Journal of Pharmaceutical Research
    • Volume 12, Supplement
    • مشاهده مورد
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Toxicity of Arsenic (III) on Isolated Liver Mitochondria: A New Mechanistic Approach

    (ندگان)پدیدآور
    Hosseini, Mir-JamalShaki, Fatemeh ShakiGhazi-Khansari, Mahmoud Ghazi-KhansariPourahmad, Jalal
    Thumbnail
    دریافت مدرک مشاهده
    FullText
    اندازه فایل: 
    811.5کیلوبایت
    نوع فايل (MIME): 
    PDF
    نوع مدرک
    Text
    Research article
    زبان مدرک
    English
    نمایش کامل رکورد
    چکیده
    Arsenic exposure mainly through food and water has been shown to be associated with increased incidence of numerous cancers and non-cancer harmful health. It is also used in cancer chemotherapy and treatment of several cancer types due to its apoptogenic effects in the various cancer and normal cell lines. We have already reported that liver is the storage site and important target organ in As (III) toxicity and recently, it has been suggested that hepatic toxicity of arsenic could be resulted from impairment of the liver mitochondria. In this study, interaction of As (III) with freshly isolated rat mitochondria was investigated. We determined different mitochondrial toxicity factors as well as mitochondrial sources of ROS formation using specific substrates and inhibitors following addition of As (III) to the mitochondria. Our results showed that arsenic (III) increased mitochondrial ROS formation, lipid peroxidation and mitochondrial membrane potential collapse, cytochrome c release and mitochondrial swelling in a concentration dependent manner. Addition of As (III) in to the isolated mitochondria, inhibited complexes I and II  leading to disruption of mitochondrial electron transfer chain, decreased mitochondrial ATP content and ROS formation.
    کلید واژگان
    Arsenic (III)
    Mitochondria
    Complex I
    Complex II
    Reactive oxygen species (ROS)
    mitochondrial permeability transition (MPT)
    liver toxicity
    toxicology and Pharmacology

    تاریخ نشر
    2013-03-01
    1391-12-11
    ناشر
    School of Pharmacy, Shahid Beheshti University of Medical Sciences
    سازمان پدید آورنده
    1- Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 2- Department of Pharmacology and Toxicology, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran. 3- Student Research Committee, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
    1- Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 2- Department of Pharmacology and Toxicology, School of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
    Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
    Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

    شاپا
    1735-0328
    1726-6890
    URI
    https://dx.doi.org/10.22037/ijpr.2013.1279
    http://ijpr.sbmu.ac.ir/article_1279.html
    https://iranjournals.nlai.ir/handle/123456789/311870

    مرور

    همه جای سامانهپایگاه‌ها و مجموعه‌ها بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌هااین مجموعه بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌ها

    حساب من

    ورود به سامانهثبت نام

    آمار

    مشاهده آمار استفاده

    تازه ترین ها

    تازه ترین مدارک
    © کليه حقوق اين سامانه برای سازمان اسناد و کتابخانه ملی ایران محفوظ است
    تماس با ما | ارسال بازخورد
    قدرت یافته توسطسیناوب